
Pharmaceutical
Amgen to invest $600M in new R&D facility in California
Biopharmaceutical giant Amgen announced Tuesday that it will invest more than $600 million to build a state-of-the-art research and development facility at its headquarters in Thousand Oaks, California. The move underscores the industry’s renewed push to strengthen U.S.-based operations amid mounting political pressure to reduce reliance on